SNRK expression was found to be decreased in human colon cancer tissues, while overexpression of SNRK inhibited colon cancer cell proliferation by upregulating calcyclin-binding protein (CacyBP) and promoting β-catenin degradation [23]. Here, SNRK is linked to malignant colon neoplasm.